Dinah Weissmann has served as Biocortech Chief Executive Officer since the founding of the company in 2001. Dr Weissmann is an expert in neurobiology, with 20 years’ experience in R&D; management. Prior to founding Biocortech, Dinah was a Senior Scientist at Roussel Uclaf (now Sanofi-Aventis). Her research background includes an appointment as a Research Director at the CNRS (Center for National Research and Science). She was also a co-founder of the CNRS Neuropharmacology lab at Lyon University. She is the author of 55 scientific publications and 6 patents in the field of neurosciences.
She was a member of the “Commission pour la Libération de la Croissance Française” led by J. Attali in 2008 and she is currently on the Board of Medicen Ile de France. She was also appointed (2009) by the French Ministry of Research to define the new national strategy for research and innovation.
Dinah received her PharmD and PhD from Strasbourg University, a leading European neurosciences centre.